Kontrol Energy (CSE: KNR) provided an update to the market this morning, announcing that it has “recently reviewed various applications for professional and amateur sports,” from potential customer applications. Further, the company has entered into a non-disclosure agreement with a leading medical sports authority.
The NDA has reportedly been entered into to share the BioCloud’s patents and research with the authority. The company is reportedly doing so to enable the advancement of potential sport application, such as in dressing rooms and training facilities.
In terms of international markets, the company reportedly added a South Korean operation to its distribution network. Also noteworthy is that the company has started the CE approval process to enable the BioCloud device to be sold in European markets. Once granted, the company may be required to achieve further standards on a country-by-country basis.
Finally, the company has indicated that it is in the process of assembling a “viral/pathogen” advisory committee that will be utilized to accelerate the application of BioCloud units.
Kontrol Energy last traded at $2.80 on the CSE.
Information for this briefing was found via Sedar and Kontrol Energy Systems. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
